Cargando…

Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies

As lifestyle and diet structure impact our health, non-alcoholic fatty liver disease (NAFLD) is prevalent all over the world. Some phytomedicines containing berberine (BBR) have been extensively used for centuries in Ayurvedic and traditional Chinese medicine. The goal of this systematic review is t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Sichen, Ma, Xiao, Wang, Ruilin, Liu, Honghong, Wei, Ying, Wei, Shizhang, Jing, Manyi, Zhao, Yanling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458904/ https://www.ncbi.nlm.nih.gov/pubmed/34566663 http://dx.doi.org/10.3389/fphar.2021.742465

Ejemplares similares

Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism
por: Tong, Yuling, et al.
Publicado: (2021)

Berberine inhibits IFN-γ signaling pathway in DSS-induced ulcerative colitis
por: Yang, Tao, et al.
Publicado: (2022)

Rutaecarpine Ameliorates Ethanol-Induced Gastric Mucosal Injury in Mice by Modulating Genes Related to Inflammation, Oxidative Stress and Apoptosis
por: Ren, Sichen, et al.
Publicado: (2020)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Chen, Lisheng, et al.
Publicado: (2021)

Metabolomics Profiles Associated with the Treatment of Zuojin Pill on Patients with Chronic Nonatrophic Gastritis
por: Ma, Xiao, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Chen, Lisheng, et al.
Publicado: (2021)

Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis
por: Li, Yubing, et al.
Publicado: (2023)

Clinical Efficacy and Safety of Shashen Maidong Decoction in the Treatment of Pediatric Mycoplasma Pneumonia: A Systematic Review and Meta-Analysis
por: Wang, Jiawei, et al.
Publicado: (2021)

Based on Network Pharmacology to Explore the Potential Bioactive Compounds and Mechanisms of Zuojin Pill for the Treatment of Ulcerative Colitis
por: Wei, Ying, et al.
Publicado: (2021)

Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Wei, Shizhang, et al.
Publicado: (2020)

Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis
por: Xie, Shuying, et al.
Publicado: (2023)

UPLC-Q-TOF/MS-Based Serum and Urine Metabonomics Study on the Ameliorative Effects of Palmatine on Helicobacter pylori–Induced Chronic Atrophic Gastritis
por: Chen, Xing, et al.
Publicado: (2020)

Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
por: He, Xuan, et al.
Publicado: (2023)

Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice
por: Wei, Shizhang, et al.
Publicado: (2023)

The Modulatory Properties of Li-Ru-Kang Treatment on Hyperplasia of Mammary Glands Using an Integrated Approach
por: Wei, Shizhang, et al.
Publicado: (2018)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies
por: Hu, Shuangyuan, et al.
Publicado: (2022)

Huanglian Jiedu Decoction Exerts Antipyretic Effect by Inhibiting MAPK Signaling Pathway
por: Li, Xing, et al.
Publicado: (2021)

Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis
por: Rafiei, Hossein, et al.
Publicado: (2023)

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
por: Yan, Hong-Mei, et al.
Publicado: (2015)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases—A Mini Review
por: Ma, Xiao, et al.
Publicado: (2020)

Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review
por: Wen, Jianxia, et al.
Publicado: (2020)

Clinical Efficacy and Safety of Xinmailong Injection for the Treatment of Chronic Heart Failure: A Meta-Analysis
por: Lu, Xiaohua, et al.
Publicado: (2018)

Berberine Attenuates Macrophages Infiltration in Intracranial Aneurysms Potentially Through FAK/Grp78/UPR Axis
por: Quan, Kai, et al.
Publicado: (2018)

Mechanism of Hydrophobic Bile Acid-Induced Hepatocyte Injury and Drug Discovery
por: Wei, Shizhang, et al.
Publicado: (2020)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
por: Dong, Yuan, et al.
Publicado: (2022)

Berberine in Non-Alcoholic Fatty Liver Disease—A Review
por: Koperska, Anna, et al.
Publicado: (2022)

Current Evidence and Future Directions of Berberine Intervention in Depression
por: Zhu, Wen-Qian, et al.
Publicado: (2022)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022)

Paeoniflorin Protects against ANIT-Induced Cholestatic Liver Injury in Rats via the Activation of SIRT1-FXR Signaling Pathway
por: Chen, Lisheng, et al.
Publicado: (2021)

Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms
por: Zhu, Peng-Chong, et al.
Publicado: (2023)

Evaluation of the Antibacterial Effects of Flavonoid Combination from the Leaves of Dracontomelon dao by Microcalorimetry and the Quadratic Rotary Combination Design
por: Li, Yang, et al.
Publicado: (2017)

Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies
por: Hao, Yanwei, et al.
Publicado: (2022)

Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model
por: Chen, Bo, et al.
Publicado: (2020)

Cardioprotective effect of curcumin on myocardial ischemia/reperfusion injury: a meta-analysis of preclinical animal studies
por: Zeng, Yi-Fan, et al.
Publicado: (2023)

GABA(B) receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence
por: Agabio, Roberta, et al.
Publicado: (2014)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9lu2m24q0teutkdr07umpvtomr